DOI: 10.12890/2025_005525
When serology fails: recognising systemic lupus erythematosus in the absence of autoantibodies
Authors
dr.khawla25@yahoo.com
Keywords
Seronegative systemic lupus erythematosus, renal biopsy, immunosuppressive therapy, autoantibodiesAbstract
The diagnosis of systemic lupus erythematosus (SLE) typically relies on characteristic autoantibodies and standardised classification criteria, and these serological markers guide both diagnosis and treatment decisions. But in rare cases, patients present with seronegative disease, creating significant diagnostic challenges that can delay appropriate intervention. Therefore, we present a case demonstrating the importance of clinical vigilance and histopathological confirmation in seronegative SLE. A 43-year-old woman with hypothyroidism developed inflammatory polyarthritis with consistently negative autoimmune serologies – rheumatoid factor, anti-cyclic citrullinated peptide antibodies, antinuclear antibodies, and anti–double-stranded deoxyribonucleic acid antibodies – despite elevated inflammatory markers. Initial treatment with hydroxychloroquine and corticosteroids elicited a significant therapeutic response. After 5 years, she developed a rapid decline in renal function with nephritic-range proteinuria. Renal biopsy revealed crescentic immune-complex glomerulonephritis with IgG, IgM, C3, and C1q deposits, confirming lupus nephritis. Aggressive therapy with intravenous methylprednisolone, plasma exchange, and cyclophosphamide, followed by maintenance therapy with mycophenolate mofetil, hydroxychloroquine, and oral corticosteroids, achieved clinical improvement and renal stabilisation. This case demonstrates that negative serologies should not preclude a diagnosis of SLE when the clinical presentation suggests systemic autoimmunity. Early renal biopsy and aggressive immunosuppression can prevent irreversible organ damage in seronegative disease. These findings support recognising seronegative SLE as a distinct disease subset and advocate for more inclusive diagnostic approaches beyond serological testing.
References
- Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol 2020;16:565-579. doi: 10.1038/s41584-020-0480-7
- Manca E. Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease? Clin Rev Allergy Immunol 2022;63:194-209. doi: 10.1007/s12016-021-08865-2
- Ozdemir F, Elsurer R, Akcay A, Ozdemir BH, Sezer S, Kuscu E, et al. Seronegative systemic lupus erythematosus: Etiology of nephrotic syndrome and acute renal failure in the early postpartum period. Lupus 2005;14:629-631. doi: 10.1191/0961203305lu2148cr
- Wajid S, Grigoryan L, Pal A, Peredo-Wende RA. Glomerulonephritis (GN) Due to Systemic Lupus Erythematosus in a Seronegative Patient: A Lupus Criteria Dilemma: SA-PO871. J Am Soc Nephrol 2024;35:10.1681. doi: 10.1681/ASN.202400ptgqce
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019;78:1151-1159. doi: 10.1136/annrheumdis-2018-214819
- Muralidharan K, Rao R. Antinuclear antibody-negative systemic lupus erythematosus. Clin Dermatol Rev 2023;7:120–123. doi:10.4103/cdr.cdr_63_21.7
- Rodriguez-Ramirez S, Wiegley N, Mejia-Vilet JM. Kidney Biopsy in Management of Lupus Nephritis: A Case-Based Narrative Review. Kidney Med 2023;6:100772. doi: 10.1016/j.xkme.2023.100772
- Kyrieleis HA, Levtchenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 2007;49:592-597. doi: 10.1053/j.ajkd.2007.02.270
- Li H, Zheng Y, Chen L, Lin S. Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify? Arch Rheumatol 2022;37:626-634. doi: 10.46497/ArchRheumatol.2022.9366
- Rampersad AG, Boylan B, Miller CH, Shapiro A. Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients. Haemophilia 2018;24:807-814. doi: 10.1111/hae.13565
